115 related articles for article (PubMed ID: 32284788)
1. Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma.
Rajesh Y; Biswas A; Banik P; Pal I; Das S; Borkar SA; Sardana H; Saha A; Das SK; Emdad L; Fisher PB; Mandal M
Oncotarget; 2020 Mar; 11(13):1097-1108. PubMed ID: 32284788
[TBL] [Abstract][Full Text] [Related]
2. Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma.
Rajesh Y; Biswas A; Kumar U; Banerjee I; Das S; Maji S; Das SK; Emdad L; Cavenee WK; Mandal M; Fisher PB
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12324-12331. PubMed ID: 32409605
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
4. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.
Ben-David Y; Giddens EB; Letwin K; Bernstein A
Genes Dev; 1991 Jun; 5(6):908-18. PubMed ID: 2044959
[TBL] [Abstract][Full Text] [Related]
5. Fli-1 promotes proliferation and upregulates NANOGP8 expression in T-lymphocyte leukemia cells.
Park SW; Do HJ; Choi W; Kim JH
Biochimie; 2020 Jan; 168():1-9. PubMed ID: 31626853
[TBL] [Abstract][Full Text] [Related]
6. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
7. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma.
Cai T; Liu Y; Xiao J
Cancer Med; 2018 Apr; 7(4):1404-1415. PubMed ID: 29479863
[TBL] [Abstract][Full Text] [Related]
9. Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma.
Rajesh Y; Biswas A; Kumar U; Das S; Banerjee I; Banik P; Bharti R; Nayak S; Ghosh SK; Mandal M
Biochem Pharmacol; 2019 Jun; 164():1-16. PubMed ID: 30885764
[TBL] [Abstract][Full Text] [Related]
10. Structure and expression of human Fli-1 gene.
Prasad DD; Rao VN; Reddy ES
Cancer Res; 1992 Oct; 52(20):5833-7. PubMed ID: 1394211
[TBL] [Abstract][Full Text] [Related]
11. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.
Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB
Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258
[TBL] [Abstract][Full Text] [Related]
12. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
13. Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition.
Rajesh Y; Biswas A; Mandal M
Exp Cell Res; 2017 Oct; 359(2):299-311. PubMed ID: 28844885
[TBL] [Abstract][Full Text] [Related]
14. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
[TBL] [Abstract][Full Text] [Related]
15. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
[TBL] [Abstract][Full Text] [Related]
16. Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines.
Baroni M; Marie SKN; Fedatto PF; Andrade AF; Suazo VK; Cruzeiro GAV; de Paula Queiroz R; Tone LG; Scrideli CA
J Neurooncol; 2018 Aug; 139(1):51-60. PubMed ID: 29671197
[TBL] [Abstract][Full Text] [Related]
17. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
[TBL] [Abstract][Full Text] [Related]
18. TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells.
Tian T; Li A; Lu H; Luo R; Zhang M; Li Z
Biochem Biophys Res Commun; 2015 Aug; 463(4):638-43. PubMed ID: 26043698
[TBL] [Abstract][Full Text] [Related]
19. miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma.
Li Y; Liu Y; Ren J; Deng S; Yi G; Guo M; Shu S; Zhao L; Peng Y; Qi S
J Neurooncol; 2018 Jul; 138(3):499-508. PubMed ID: 29876787
[TBL] [Abstract][Full Text] [Related]
20. The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling.
Peng C; Chen Z; Wang S; Wang HW; Qiu W; Zhao L; Xu R; Luo H; Chen Y; Chen D; You Y; Liu N; Wang H
Cancer Res; 2016 Apr; 76(8):2340-53. PubMed ID: 26960975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]